Inflammatory status, arterial stiffness and central hemodynamics in hypertensive patients with metabolic syndrome

Artery Research

Volumn 3, Issue 3, 2009, Pages 115-121

  Pietri, Panagiota ^a   Vlachopoulos, Charalambos ^a   Aznaouridis, Konstantinos ^a   Baou, Katerina ^a   Xaplanteris, Panagiotis ^a   Dima, Ioanna ^a   Vyssoulis, Gregory ^a   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Arterial hypertension; Arterial stiffness; Central blood pressures; Inflammation; Metabolic syndrome; Wave reflections

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AORTA PRESSURE; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MONITORING; CAROTID ARTERY PULSE; CIGARETTE SMOKING; FEMALE; HEART RATE VARIABILITY; HEMODYNAMICS; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PULSE WAVE; WAIST CIRCUMFERENCE;

EID: 70449107043     PISSN: 18729312     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.artres.2009.09.001     Document Type: Article

References (51)

1. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49 (2007) 403-414
2. Schillaci G., Pirro M., Vaudo G., Gemelli F., Marchesi S., Porcellati C., et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 43 (2004) 1817-1822
3. Ford E. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count:findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168 (2003) 351-358
4. Wannamethee S.G., Lowe G.D.O., Shaper A.G., Rumley A., Lennon L., and Whincup P. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis 181 (2005) 101-108
5. Laurent S., Cockcroft J., van Bortel L., Boutouyrie P., Giannatasio C., Hayoz D., et al. On behalf of the European Network for Non-invasive investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27 (2006) 2588-2605
6. Agabiti-Rosei E., Mancia G., O'Rourke M.F., Roman M.J., Safar M.E., Smulyan H., et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 50 (2007) 154-160
7. van People N.M., Westendorp I.C., Bots M.L., Reneman R.S., Hoeks A.P., Hofman A., et al. Variables of the insulin resistance syndrome are associated with reduced arterial distensibility in healthy non-diabetic middle-aged women. Diabetologia 43 (2000) 665-672
8. Safar M., Thomas F., Blacher J., Nzietchueng R., Bureau J.M., Pannier B., et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 47 (2006) 72-75
9. Protogerou A., Blacher J., Aslangul E., Le Jeunne C., Lekakis J., Mavrikakis M., et al. Gender influence on metabolic syndrome's effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects. Atherosclerosis 193 (2007) 151-158
10. Scuteri A., Najjar S., Muller D., Andres R., Hougaku H., Metter J., et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
11. Czernichow S., Bertrais S., Blacher J., Oppert J.M., Galan P., Ducimetière P., et al. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. Am J Hypertens 18 (2005) 1154-1160
12. Schillaci G., Pirro M., Vaudo G., Mannarino M., Savarese G., Pucci G., et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 45 (2005) 1078-1082
13. El Feghali R., Topouchian J., Pannier B., and Asmar R. Ageing and blood pressure modulate the relationship between metabolic syndrome and aortic stiffness in never-treated essential hypertensive patients. A comparative study. Diabetes Metab 33 (2007) 183-188
14. Mulè G., Cottone S., Mongiovi R., Cusimano P., Mezzatesta G., Seddio G., et al. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr Metab Cardiovasc Dis 16 (2006) 54-59
15. Vyssoulis G.P., Pietri P.G., Karpanou E.A., Vlachopoulos C.V., Kyvelou S.M., Spanos P., et al. Differential impact of metabolic syndrome on arterial stiffness and wave reflections: Focus on distinct definitions. Int J Cardiol (2008) [Epub ahead of print]
16. Plantinga Y., Ghiadoni L., Magagna A., Giannarelli C., Penno G., Pucci L., et al. Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens 26 (2008) 1216-1222
17. Vlachopoulos C., Dima I., Aznaouridis K., Vasiliadou C., Ioakeimidis N., Aggeli C., et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112 (2005) 2193-2200
18. Yasmin M.C., Wallace S., Mackenzie I., Cockcroft J., and Wilkinson I. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vascul Biol 24 (2004) 969-974
19. Pietri P., Vyssoulis G., Vlachopoulos C., Zervoudaki A., Gialernios T., Aznaouridis K., et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 24 (2006) 2231-2238
20. Mahmud A., and Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 46 (2005) 1118-1122
21. Vlachopoulos C., Pietri P., Aznaouridis K., Vyssoulis G., Vasiliadou C., Bratsas A., et al. Relationship of fibrinogen with arterial stiffness and wave reflections. J Hypertens 25 (2007) 2110-2116
22. Tomiyama H., Koji Y., Yambe M., Kohki M., Shiina K., Gulnisa Z., et al. Elevated C-reactive protein augments increased arterial stiffness in subjects with metabolic syndrome. Hypertension 45 (2005) 997-1003
23. Ferreira I., Boreham C., Twisk J., Gallagher A., Young I., Murray L., et al. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults:the Northern Ireland Young Hearts Project. J Hypertens 25 (2007) 1009-1020
24. Wildman R., Mackey R., Bostom A., Thompson T., and Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 42 (2003) 468-473
25. Castell J.V., Gomez-Lechon M.J., David M., Fabra R., Trullenque R., and Heinrich P.C. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12 (1990) 1179-1186
26. Wang C.-H., Li S.-H., Weisel R., Fedak P., Dumont A., Szmitko P., et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107 (2003) 1783-1790
27. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
28. Clapp B., Hirschfield G., Storry C., Gallimore J.R., Stidwill R., Singer M., et al. Inflammation and endothelial function. Direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 111 (2005) 1530-1536
29. Tsioufis C., Dimitriadis K., Selima M., Thomopoulos C., Mihas C., Skiadas I., et al. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J 28 (2007) 1162-1169
30. Schumacher W., Cockcroft J., Timpson N.J., McEniery C.M., Gallacher J., Rumley A., et al. Association between C-reactive protein genotype, circulating levels and aortic pulse wave velocity. Hypertension 53 (2009) 150-157
31. Vlachopoulos C., Terentes-Printzios D., Dima I., Aznaouridis K., and Stefanadis C. Polymorphims of inflammatory markers/mediators and arterial stiffness. Hypertension 53 (2009) e39
32. Lund T., and Osterud B. Fibrinogen increases lipopolysaccharide-induced tumor necrosis factor-a and interleukin-8 release, and enhances tissue factor activity in monocytes in a modified whole blood system. Blood Coagul Fibrinolysis 12 (2001) 667-675
33. Wilkinson I.B., MacCallum H., Cockcroft J.R., and Webb D.J. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 53 (2002) 189-192
34. Harley S.L., Sturge J., and Powell J.T. Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells. Arterioscler Thromb Vasc Biol 163 (2003) 2285-2289
35. Guo M., Sahni S.K., Sahni A., and Francis C.W. Fibrinogen regulates the expression of inflammatory chemokines through NF-kappa B activation of endothelial cells. Thromb Heamost 92 (2004) 858-866
36. Feinbloom D., and Bauer K.A. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol 25 (2005) 2043-2053
37. Greenfield J.R., Samaras K., Campbell L.V., Jenkins A.B., Kelly P.J., Spector T.D., et al. Physical activity reduces genetic susceptibility to increased central systolic pressure augmentation: a study of female twins. J Am Coll Cardiol 42 (2003) 264-270
38. Maple-Brown L., Piers L., O'Rourke M., Celermajer D., and O'Dea K. Central obesity is associated with reduced peripheral reflection in Indigenous Australians irrespective of diabetes status. J Hypertens 23 (2005) 1403-1407
39. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., et al. on behalf of the European Network for Non Invasive Investigation of Large Arteries. Abridged version of the expert consensus document on arterial stiffness. Artery Res 1 (2007) 2-12
40. Vlachopoulos C., and Stefanadis C. In: Laurent S., and Cockcroft J. (Eds). Central aortic blood pressure. 1st ed (2008), Elsevier, France p 13-25
41. th ed (1998), Edward Arnold, London pp.170-222, 284-315, 347-395, 450-476.
42. Williams B., Lacy P., Thom S., Cruickshank K., Stanton A., Collier D., et al. CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; Cafe Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the conduit artery function evaluation (CAFE) study. Circulation 113 (2006) 1213-1225
43. Agata J., Nagahara D., Kinoshita S., Takagawa Y., Moniwa N., Yoshida D., et al. Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Circ J. 68 (2004) 1194-1198
44. Di Napoli M., and Papa F. Angiotensin-converting enzyme inhibitor is associated with reduced concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 34 (2003) 2922-2929
45. Fliser D., Buchholz K., and Haller H. for the European Trial on Olmesartan and Pravastatin in Inflammation and Atherosclerosis (EUTOPIA) investigators. Antiiflammatory effects of angiotensin II subtype 1 receptor blockcade in hypertensive patients with microinflammation. Circulation 110 (2004) 1103-1107
46. Fogari R., Zoppi A., Lazzari P., Preti P., Mugellini A., Corradi L., et al. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. J Cardiovasc Pharmacol 32 (1998) 616-620
47. Vyssoulis G.P., Marinakis A.G., Aznaouridis K.A., Karpanou E.A., Arapogianni A.N., Cokkinos D.V., et al. The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking. Am J Hypertens 17 (2004) 582-589
48. Devaraj S., Chan E., and Jialal I. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab 91 (2006) 4489-4496
49. Ridker P., Cushman M., Stampfer M.J., Tracy R., and Hennekens C. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N. Engl J Med 336 (1997) 973-979
50. Pitsavos C., Panagiotakos D.B., Chrysohoou C., Kavouras S., and Stefanadis C. The associations between physical activity, inflammation, and coagulation markers, in people with metabolic syndrome: the ATTICA study. Eur J Cardiovasc Prev Rehabil 12 (2005) 151-158
51. Giugliano D., Ceriello A., and Esposito K. The effects of diet on inflammation. Emphasis on the metabolic syndrome. J Am Coll Cardiol 48 (2006) 677-685